1. Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in non‐small cell lung cancer
    Runbin Sun et al, 2023, Cancer Medicine CrossRef
  2. Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future?
    Rita Lampignano et al, 2020, Molecular Aspects of Medicine CrossRef
  3. Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art
    Weronika Maria Szejniuk et al, 2019, The Pharmacogenomics Journal CrossRef
  4. Overview upon miR-21 in lung cancer: focus on NSCLC
    Cecilia Bica-Pop et al, 2018, Cellular and Molecular Life Sciences CrossRef
  5. miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer
    Shen Zhong et al, 2021, Translational Research CrossRef
  6. Circulating or tissue microRNAs and extracellular vesicles as potential lung cancer biomarkers: a systematic review
    Yan Song et al, 2018, The International Journal of Biological Markers CrossRef
  7. Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages
    Florian Janke et al, 2020, Cancers CrossRef
  8. Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands
    Sarah Sayed Hassanein et al, 2021, International Journal of Molecular Sciences CrossRef
  9. Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges
    Débora Dummer Meira et al, 2023, Genes CrossRef
  10. The MicroRNA‐326: Autoimmune diseases, diagnostic biomarker, and therapeutic target
    Golamreza Jadideslam et al, 2018, Journal of Cellular Physiology CrossRef
  11. Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma
    Long-Hua Guo et al, 2020, Frontiers in Oncology CrossRef
  12. A Large Set of miRNAs Is Dysregulated from the Earliest Steps of Human Hepatocellular Carcinoma Development
    Pia Sulas et al, 2018, The American Journal of Pathology CrossRef
  13. Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review
    Golamreza Jadideslam et al, 2019, Journal of Cellular Physiology CrossRef
  14. Circulating MicroRNAs as Potential Biomarkers for Lung Cancer
    Sabrina Müller et al, 2020, Tumor Liquid Biopsies CrossRef
  15. Omnipresence MicroRNA-483: A comprehensive organ by organ literature review
    Mehrdad Asadi et al, 2023, Human Gene CrossRef